Rapid scientific advances and mounting pressure on timelines have put biopharma at a turning point. AI/ML tools, robotics, and modern data platforms offer real gains, but only if labs can overcome siloed systems and organizational inertia.
In this webinar, DeAnna Zacherl of Eli Lilly and Malay Gandhi of Benchling share how leading teams are aligning infrastructure, data, and people to drive real change. They discuss overcoming cultural resistance and building systems that support discovery, scale, and regulatory success.
Download the webinar to:
- Learn how industry leaders integrate emerging tech across pharma and biotech R&D environments
- Understand how FAIR (findable, accessible, interoperable, and reusable) data improves efficiency and research value
- Explore proven strategies to manage adoption in complex, regulated lab settings
- See how industry leaders turn digital upgrades into faster innovation and collaboration
Panelists
DeAnna Zacherl
Executive director, technology for BIOTDR, Genetic Medicines, Neuroscience & Pain, Eli Lilly
Malay Gandhi
Chief strategy officer, Benchling
